PharmaCyte Biotech Inc (PMCB)

[Edward]

No, he didn't say that. He said "successfully completed the three-month product stability testing that is required by the U.S. Food and Drug Administration (FDA) for its CypCaps™ and CypCaps™ passed all of the FDA-required tests.

Didn't say anything about the below tasks.

In the PR right before on 6/23/2020 he stated:

Most of the remaining work is being handled by PharmaCyte’s consultants. Set forth below is a list of the major items to be finalized by PharmaCyte and its consultants before PharmaCyte submits the IND to the FDA.

Trial Protocol
Investigator’s Brochure
Environmental Analysis
General Investigation Plan
Introduction Summary
Nonclinical Overview
Clinical Overview
Nonclinical Written and Tabulated Summaries
Drug Master File
Pharmacy Manual
Informed Consent
Study Reports and related information of prior clinical studies